FDA NDC Directory · JSON-LD · Markdown
NDC 19515-822 · VACCINE · SUSPENSION
| Generic name | influenza virus vaccine |
|---|---|
| Labeler / Manufacturer | ID Biomedical Corporation of Quebec |
| Marketing category | Biologic License Application · App BLA125163 |
| Dosage form / route | SUSPENSION · INTRAMUSCULAR |
| Active ingredients | INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR 278 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (15 ug/.5mL) INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN 049A (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (15 ug/.5mL) INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (15 ug/.5mL) |
| Marketing started | 20260701 |
| Marketing ended | 20270630 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).